MedTrace Logo

Early Metabolic Changes With Thiazide or Beta Blocker Therapy for Essential Hypertension

NCT00380289 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2006-09-25

No results posted yet for this study

Summary

Can the oral glucose tolerance test detect changes after 4 weeks treatment with thiazide diuretics or beta blockers or combination of the two?

Conditions

  • Essential Hypertension

Interventions

DRUG

Thiazide and beta blocker

Sponsors & Collaborators

Principal Investigators

  • Professor MJ Brown, MA MSC MD FRCP · Addenbrookes Hosptal NHS Trust/ University of Cambridge

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00380289 on ClinicalTrials.gov